BRPI0812494A2 - Derivados de 3',4',5-trimetóxi como estimulante da secreção de muco, método de preparação do mesmo, e composição farmacêutica compreendendo o mesmo - Google Patents

Derivados de 3',4',5-trimetóxi como estimulante da secreção de muco, método de preparação do mesmo, e composição farmacêutica compreendendo o mesmo

Info

Publication number: BRPI0812494A2
Authority: BR; Brazil
Prior art keywords: preparation; pharmaceutical composition; same; mucus secretion; secretion enhancer
Prior art date: 2007-06-07

Application number

BRPI0812494-9A

Other languages

English (en)

Inventor

Seul-Min Choi

Kyung-Koo Kang

Dong-Sung Kim

Jeong-Hoon Kim

Byoung-Ok Ahn

Moo-Hi Yoo

Mi-Jeong Seo

Ju-Mi Kim

Yong-Duck Kim

Sun-Woo Jang

Yong-Sung Shon

Original Assignee

Dong A Pharm Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-07

Filing date

2008-06-02

Publication date

2015-06-16

2008-06-02 Application filed by Dong A Pharm Co Ltd filed Critical Dong A Pharm Co Ltd

2015-06-16 Publication of BRPI0812494A2 publication Critical patent/BRPI0812494A2/pt

Links

210000003097 mucus Anatomy 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
230000028327 secretion Effects 0.000 title abstract 2
239000003623 enhancer Substances 0.000 title 1
IIOQEHSFZUYICM-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-methoxychromen-4-one Chemical class C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C=CC=C2O1 IIOQEHSFZUYICM-UHFFFAOYSA-N 0.000 abstract 2
208000003556 Dry Eye Syndromes Diseases 0.000 abstract 2
206010013774 Dry eye Diseases 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
208000028006 Corneal injury Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
210000000795 conjunctiva Anatomy 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0812494-9A 2007-06-07 2008-06-02 Derivados de 3',4',5-trimetóxi como estimulante da secreção de muco, método de preparação do mesmo, e composição farmacêutica compreendendo o mesmo BRPI0812494A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR1020070055427A KR100930467B1 (ko)	2007-06-07	2007-06-07	점액분비를 촉진시키는 3',4',5-트리메톡시 플라본 유도체화합물, 그의 제조방법 및 약학적 용도
PCT/KR2008/003078 WO2008150085A2 (en)	2007-06-07	2008-06-02	3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same

Publications (1)

Publication Number	Publication Date
BRPI0812494A2 true BRPI0812494A2 (pt)	2015-06-16

Family

ID=40094296

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0812494-9A BRPI0812494A2 (pt)	2007-06-07	2008-06-02	Derivados de 3',4',5-trimetóxi como estimulante da secreção de muco, método de preparação do mesmo, e composição farmacêutica compreendendo o mesmo

Country Status (14)

Country	Link
US (1)	US8203011B2 (pt)
EP (1)	EP2170857B1 (pt)
JP (1)	JP5295230B2 (pt)
KR (1)	KR100930467B1 (pt)
CN (1)	CN101679341B (pt)
AT (1)	ATE529417T1 (pt)
AU (1)	AU2008260829B2 (pt)
BR (1)	BRPI0812494A2 (pt)
CA (1)	CA2689136C (pt)
DK (1)	DK2170857T3 (pt)
ES (1)	ES2375184T3 (pt)
MX (1)	MX2009013062A (pt)
PT (1)	PT2170857E (pt)
WO (1)	WO2008150085A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009018350A1 (en) *	2007-07-31	2009-02-05	Limerick Biopharma, Inc.	Pyrone analog compositions and methods
EP2424541A2 (en) *	2009-04-27	2012-03-07	Limerick BioPharma, Inc.	Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
CN102796066B (zh) *	2012-08-31	2014-09-03	云南民族大学	一种黄酮类化合物及其制备方法与应用
CN103059005B (zh) *	2012-11-22	2015-04-22	中南民族大学	白杨素酰胺衍生物及其医药用途
WO2017033060A1 (en) *	2015-08-24	2017-03-02	University Of Macau	Composition for treating dry eye diseases and sjögren's syndrome
CN107373745B (zh) *	2017-07-28	2020-04-03	云南中烟工业有限责任公司	一种防止烟草料液腐败变质的添加剂及其应用
KR102040810B1 (ko) *	2018-01-31	2019-11-05	인제대학교 산학협력단	알파-휴물렌을 유효성분으로 함유하는 안구 건조증 예방 또는 치료용 조성물
KR102685191B1 (ko) *	2021-07-26	2024-07-15	동아제약 주식회사	레코플라본 또는 이의 염을 포함하는 피부개선용 화장료 조성물
US20250082603A1 (en) *	2021-08-05	2025-03-13	Gl Pharmtech Corp.	Ophthalmic composition containing recoflavone for the treatment of dry eye disease and method for preparing the same
CN117794515A (zh) *	2021-08-05	2024-03-29	格里医药科技公司	用于治疗干眼综合征的包含瑞可黄酮的滴眼剂组合物及其制备方法
KR102356603B1 (ko) *	2021-08-05	2022-02-08	지엘팜텍주식회사	안구건조증 치료를 위한 레코플라본 함유 점안 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA873745B (en) *	1986-06-04	1988-10-26	Daiichi Seiyaku Co	Benzopyran derivatives
DE3628590A1 (de) *	1986-08-22	1988-02-25	Musikon Gmbh	Raumeinheit fuer die aufnahme und/oder wiedergabe von akustischen signalen
US5006550A (en) *	1989-12-29	1991-04-09	Allergan, Inc.	Chroman esters of phenols and benzoic acids having retinoid-like activity
KR100447918B1 (ko) *	1996-07-25	2005-09-28	동아제약주식회사	대장을포함한위장관보호작용을갖는플라본및플라바논화합물
FR2753969B1 (fr)	1996-09-27	1998-10-30	Adir	Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP3957795B2 (ja) *	1996-10-04	2007-08-15	興和株式会社	フラボン誘導体及びこれを含有する医薬
JPH11279062A (ja) *	1998-01-30	1999-10-12	Fujisawa Pharmaceut Co Ltd	眼科用剤
KR100327621B1 (ko)	1999-09-22	2002-03-15	유충식	7-카르복시메틸옥시-3',4',5-트리메톡시플라본의 제조방법
JP2001233775A (ja) *	2000-02-28	2001-08-28	Cci Corp	涙液分泌促進剤
KR20050024121A (ko) *	2003-09-04	2005-03-10	동아제약주식회사	7-카르복시메틸옥시-3',4',5-트리메톡시 플라본.일수화물, 이의 제조방법 및 용도
US8017649B2 (en)	2005-03-11	2011-09-13	Howard Florey Institute Of Experimental Physiology And Medicine	Flavonoid compounds and uses thereof
DK2444079T3 (en) *	2005-05-17	2017-01-30	Sarcode Bioscience Inc	Compositions and Methods for the Treatment of Eye Diseases

2007
- 2007-06-07 KR KR1020070055427A patent/KR100930467B1/ko active Active
2008
- 2008-06-02 CN CN2008800190634A patent/CN101679341B/zh not_active Expired - Fee Related
- 2008-06-02 WO PCT/KR2008/003078 patent/WO2008150085A2/en not_active Ceased
- 2008-06-02 MX MX2009013062A patent/MX2009013062A/es active IP Right Grant
- 2008-06-02 ES ES08766040T patent/ES2375184T3/es active Active
- 2008-06-02 BR BRPI0812494-9A patent/BRPI0812494A2/pt not_active IP Right Cessation
- 2008-06-02 DK DK08766040.3T patent/DK2170857T3/da active
- 2008-06-02 US US12/451,902 patent/US8203011B2/en not_active Expired - Fee Related
- 2008-06-02 AU AU2008260829A patent/AU2008260829B2/en not_active Ceased
- 2008-06-02 JP JP2010511105A patent/JP5295230B2/ja not_active Expired - Fee Related
- 2008-06-02 PT PT08766040T patent/PT2170857E/pt unknown
- 2008-06-02 AT AT08766040T patent/ATE529417T1/de active
- 2008-06-02 CA CA2689136A patent/CA2689136C/en not_active Expired - Fee Related
- 2008-06-02 EP EP08766040A patent/EP2170857B1/en active Active

Also Published As

Publication number	Publication date
EP2170857A2 (en)	2010-04-07
PT2170857E (pt)	2011-12-12
WO2008150085A2 (en)	2008-12-11
MX2009013062A (es)	2010-01-18
KR20080107542A (ko)	2008-12-11
AU2008260829B2 (en)	2012-11-08
EP2170857B1 (en)	2011-10-19
JP5295230B2 (ja)	2013-09-18
ATE529417T1 (de)	2011-11-15
ES2375184T3 (es)	2012-02-27
CA2689136C (en)	2012-11-13
US8203011B2 (en)	2012-06-19
EP2170857A4 (en)	2010-06-23
WO2008150085A3 (en)	2009-02-26
CN101679341A (zh)	2010-03-24
US20100130448A1 (en)	2010-05-27
CN101679341B (zh)	2012-06-06
DK2170857T3 (da)	2011-12-05
KR100930467B1 (ko)	2009-12-08
CA2689136A1 (en)	2008-12-11
AU2008260829A1 (en)	2008-12-11
JP2010529112A (ja)	2010-08-26

Similar Documents

Publication	Publication Date	Title
BRPI0812494A2 (pt)	2015-06-16	Derivados de 3',4',5-trimetóxi como estimulante da secreção de muco, método de preparação do mesmo, e composição farmacêutica compreendendo o mesmo
NO20075660L (no)	2008-02-22	Blanding for behandling av inflammatoriske sykdommer
ZA200709251B (en)	2009-08-26	Suspension formulations comprising an active principle, a poloxamer or meroxapol surfactant and a glycol, its use for the manufacture of a medicament for treating ophthalmic disorders
EP4344743A3 (en)	2024-06-19	Heterocyclic flavone derivatives, compositions, and methods related thereto
WO2008011836A3 (es)	2008-07-31	Soluciones oftálmicas
EA200800798A1 (ru)	2008-10-30	Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха
WO2009109613A3 (en)	2009-12-10	1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1
CY1108676T1 (el)	2014-04-09	Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων
UA92000C2 (en)	2010-09-27	1-benzylindole-2-carboxamide derivatives
WO2009109616A8 (en)	2010-08-12	1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
WO2009061431A3 (en)	2009-07-23	Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
WO2009041663A1 (ja)	2009-04-02	皮膚疾患の予防及び／または治療剤
ECSP066608A (es)	2006-10-25	Suspensiones acuosas de ciclesonide para nebulización
MX2010009624A (es)	2010-09-28	Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1.
WO2008070010A3 (en)	2008-07-24	Hydroxylamine derivatives for the treatment of stroke
IL179012A0 (en)	2007-03-08	Method and composition for treating rhinitis
NO20092764L (no)	2009-07-27	Isosorbid mononitrat derivater for behandling av okular hypertensjon
WO2007077203A3 (en)	2007-08-30	Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases
WO2009041786A3 (en)	2009-05-14	Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from piper longum for the prevention and treatment of inflammatory disease
RU2008102249A (ru)	2009-07-27	Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания
WO2019004788A3 (ko)	2019-02-28	브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물
MXPA05014143A (es)	2006-02-24	Derivados de cumarina para el tratamiento de trastornos oftalmicos.
WO2007023072A3 (en)	2007-05-03	Use of ambroxol for the treatment of rhinovirus infections
PT1490049E (pt)	2006-08-31	Citalopram para o tratamento da pre3ssao sanguinia elevada.
EP4234037A3 (en)	2023-09-06	Liquid compositions for peroral use comprising phosphatidylglycerol derivatives and thixotropic excipients for treating cardiac channelopathies caused by pharmacological agents

Legal Events

Date	Code	Title	Description
2016-09-13	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 8A ANUIDADE.
2017-01-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.